Voltage-gated sodium channels (Navs) are involved in several aspects of the pathogenesis of multiple sclerosis (MS). Within acute MS plaques, they are expressed along demyelinated axons. Studies in experimental autoimmune encephalomyelitis (EAE) demonstrated a neuroprotective effect of non-specific Nav blockers. Further, block of specific Navs involved in MS is suggested to have an advantage over non-specific blockers. We investigated the effects of the synthetic Midi peptide in EAE, as it potently and specifically blocks Nav1.2, Nav1.4 and Nav1.6. Administration of this Midi peptide worsens the clinical disease pattern and Nav1.2 and Nav1.6 expression levels were elevated in brain but not in spinal cord of Midi-treated mice, implicating th...
Transient receptor potential vanilloid 1 (TRPV1) channels are involved in several inflammatory disea...
Axonal degeneration is a major cause of permanent disability in multiple sclerosis (MS). Recent obse...
Objective: Despite progress in treating relapsing multiple sclerosis (MS), effective inhibition of n...
Voltage-gated sodium channels (Navs) are key players in the generation and propagation of electrical...
Cerebellar symptoms significantly diminish quality of life in patients with multiple sclerosis (MS)....
Multiple sclerosis (MS) is a demyelinating inflammatory disease of the central nervous system (CNS) ...
Abstract—Sodium channels are expressed at high density in myelinated axons and play an obligatory ro...
Cerebellar symptoms significantly diminish quality of life in patients with multiple sclerosis (MS)....
It is increasingly accepted that excessive glutamate release plays a key role in the pathophysiology...
Astrogliosis is a hallmark of central nervous system (CNS) neuroinflammatory disorders such as multi...
AbstractMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system char...
Our investigations have aimed to reveal more details in the mechanisms underlying the autoimmune neu...
Multiple Sclerosis is a chronic demyelinating disease of the central nervous system of undetermined ...
BACKGROUND AND PURPOSE: Increasing evidence shows the dysregulation of glutamate transmission in bo...
Pharmacological targeting of ion channels has long been recognized as an attractive strategy for the...
Transient receptor potential vanilloid 1 (TRPV1) channels are involved in several inflammatory disea...
Axonal degeneration is a major cause of permanent disability in multiple sclerosis (MS). Recent obse...
Objective: Despite progress in treating relapsing multiple sclerosis (MS), effective inhibition of n...
Voltage-gated sodium channels (Navs) are key players in the generation and propagation of electrical...
Cerebellar symptoms significantly diminish quality of life in patients with multiple sclerosis (MS)....
Multiple sclerosis (MS) is a demyelinating inflammatory disease of the central nervous system (CNS) ...
Abstract—Sodium channels are expressed at high density in myelinated axons and play an obligatory ro...
Cerebellar symptoms significantly diminish quality of life in patients with multiple sclerosis (MS)....
It is increasingly accepted that excessive glutamate release plays a key role in the pathophysiology...
Astrogliosis is a hallmark of central nervous system (CNS) neuroinflammatory disorders such as multi...
AbstractMultiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system char...
Our investigations have aimed to reveal more details in the mechanisms underlying the autoimmune neu...
Multiple Sclerosis is a chronic demyelinating disease of the central nervous system of undetermined ...
BACKGROUND AND PURPOSE: Increasing evidence shows the dysregulation of glutamate transmission in bo...
Pharmacological targeting of ion channels has long been recognized as an attractive strategy for the...
Transient receptor potential vanilloid 1 (TRPV1) channels are involved in several inflammatory disea...
Axonal degeneration is a major cause of permanent disability in multiple sclerosis (MS). Recent obse...
Objective: Despite progress in treating relapsing multiple sclerosis (MS), effective inhibition of n...